CAR NKT cells, a promising step forward in the treatment of solid tumors
An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.
Read more
neuroblastoma
Understanding the cancer risk in children with birth defects
Understanding the cancer risk in children with birth defects has been a challenge. Although scientific studies suggest that birth defects increase the risk of cancer,
Read more
From the labs to bedside: First-in-human trial shows promise in treating neuroblastoma
Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of
Read more